Gene · 729838
GGTLC4P: gamma-glutamyltransferase light chain 4 pseudogene
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. GGTLC4P: gamma-glutamyltransferase light chain 4 pseudogene. Genes, record 729838. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/729838
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants677
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GGTLC4P papers | Newest fiscal year |
|---|---|---|---|
| P30DK120515 | San Diego Digestive Diseases Research Center | 14 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| U01DK061734 | Clinical Research on Nonalcoholic Fatty Liver Disease | 8 | 2025 |
| P30DK034989 | Yale Liver Center | 6 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 6 | 2025 |
| P50AA011999 | Southern California Research Center for ALPD and Cirrhosis | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| R01AA024726 | The Role of the Intestinal Mycobiome in Alcoholic Liver Disease | 4 | 2025 |
| U01DK061713 | Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) | 4 | 2025 |
| I01BX004594 | The role of pathobionts in alcoholic liver disease | 3 | 2025 |
1 to 10 of 677Source NIH's project files
See all 677 nih grantsPapers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prevalence and Clinical Significance of the Hepatitis C Virus Core Protein 70Q/H Mutation and Its Association With Hepatocellular Carcinoma-Related Markers in Mexican Patients. | J Clin Exp Hepatol | 2026 | 42761524 | PubTator, text mining | PubMed |
Clinical efficacy, safety evaluation, and mechanism of acetylcysteine in improving first-line anti-tuberculosis treatment of newly diagnosed pulmonary TB: an open-label, randomized, single-center trial. | Front Med (Lausanne) | 2026 | 42718567 | PubTator, text mining | PubMed |
| Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin-3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. | Hepatol Res | 2026 | 42433192 | PubTator, text mining | PubMed |
| Angiopoietin-like Proteins 4 and 8 in Diabetic Complications: Associations with Neuropathy and Metabolic Parameters in Type 2 Diabetes. | J Clin Med | 2026 | 42194593 | PubTator, text mining | PubMed |
| MTHFR risk alleles associate with Th17 immunity and spinal damage in axial spondyloarthritis. | Clin Immunol | 2026 | 42155831 | PubTator, text mining | PubMed |
| Postoperative Adjuvant Transcatheter Arterial Chemoembolization (TACE) for Hepatocellular Carcinoma: Patient Selection and Clinical Predictors of Therapeutic Benefit. | J Hepatocell Carcinoma | 2026 | 42093753 | PubTator, text mining | PubMed |
| Performance of Serum-Based Non-Invasive Fibrosis Scores Compared with Liver Biopsy in Patients with Chronic Hepatitis B. | Medicina (Kaunas) | 2026 | 42075518 | PubTator, text mining | PubMed |
| Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver disease. | Ann Hepatol | 2026 | 42019594 | PubTator, text mining | PubMed |
| EBV-DNA viral load and lymphocyte subsets correlation in pediatric infectious mononucleosis with hepatic injury a retrospective cohort study. | Front Pediatr | 2026 | 41960032 | PubTator, text mining | PubMed |
| Leptin/Adiponectin Ratio as a new multidimensional biomarker in obese patients with liver steatosis undergoing VLEKT: results from a pilot study. | Front Nutr | 2026 | 41939193 | PubTator, text mining | PubMed |
1 to 10 of 2,390
See all 2,390 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/729838
GET https://conductscience.org/api/genes/v1/729838/grants?page=2